| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 08/04/2004 | EP1441724A1 Methods of increasing endogenous testosterone levels |
| 08/04/2004 | EP1441723A1 Use of irbesartan for the preparation of medicaments that are used to prevent or treat pulmonary hypertension |
| 08/04/2004 | EP1441719A1 N-substituted pyrrolidin derivatives as dipeptidyl peptidase iv inhibitors |
| 08/04/2004 | EP1441718A2 Carbinols for the treatment of neuropathic dysfunction |
| 08/04/2004 | EP1441683A2 Trisubstituted triazine compounds, and methods for making an using the compounds, which have antitubulin activity |
| 08/04/2004 | EP1292586B1 Process for the preparation of pyrazolopyrimidinones |
| 08/04/2004 | EP1192131B1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using isoindoline derivatives |
| 08/04/2004 | EP1189875B1 Mono and multifunctional alkoxyamines for the preparation of functionalized macromers |
| 08/04/2004 | EP1140903B1 Aromatic amides |
| 08/04/2004 | EP1123704B1 Remedies for spinal canal stenosis |
| 08/04/2004 | EP1091956B1 Muscarinic antagonists |
| 08/04/2004 | EP1076657B1 New hydroxyindoles, their use as phosphodiesterase 4 inhibitors and method for producing same |
| 08/04/2004 | EP1070714B1 Amidine compounds |
| 08/04/2004 | EP0984944B1 Substituted 4-(3-alkenyl-benzoyl)-pyrazoles |
| 08/04/2004 | EP0961618B1 5-Pyrimidinyl-4-yl-Imidazole Derivate zur Behandlung von CSBP/RK/p38 vermittelten Erkrankungen |
| 08/04/2004 | CN1518548A Teterocyclyloxy-thioxy-and-aminobenzazole derivatives as 5-Hydroxytryptamine-6-ligands |
| 08/04/2004 | CN1518547A Heterocyclyloxy-thioxy-and-aminobenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 08/04/2004 | CN1518546A Selective anthranilamide pyridine amides as inhibitors of VEGRF-2 and VEGFR-3 |
| 08/04/2004 | CN1518543A Pyrazole derivatives and their use as protein kinase inhibitors |
| 08/04/2004 | CN1518542A Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes |
| 08/04/2004 | CN1518541A Phenyl derivatives |
| 08/04/2004 | CN1518534A Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 08/04/2004 | CN1518460A Composition comprising PDE-4 inhibitor and H1-receptor antagonist and use thereof for manufacture of medicament for treatment of respiratory diseases |
| 08/04/2004 | CN1518449A Pediatric formulation of gatifloxacin |
| 08/04/2004 | CN1518447A Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic agents |
| 08/04/2004 | CN1160350C Method for preparing asymmetric lactone |
| 08/04/2004 | CN1160349C Pyrazole derivatives and processes for producing the same, and pesticides containing the same as the active ingredient |
| 08/04/2004 | CN1160348C Aryl-{4-fluoro-4-{(2-pyridin-2-YL-ethylamino)-methyl]-piperidin-yl}-methanone derivatives as 5-HT1 receptor antagonists |
| 08/04/2004 | CN1160347C Novel anthrapyridone compounds, water-based magenta ink composition, and method of ink-jet printing |
| 08/04/2004 | CN1160344C Compounds for treatment of asthma, allergy and inflammatory disorders and its use |
| 08/04/2004 | CN1160081C Combination therapy of HIV infection using HIV protease inhibitior induinavir and reverse transcriptase inhibitor 3TC, optionally together with AZT, DDI or DDC |
| 08/04/2004 | CN1160073C Use of halofuginone for preparing medicine for treating cirrhosis |
| 08/04/2004 | CN1160071C Use of substiuted 2,4-imidazolidinedione compounds as analgesics |
| 08/04/2004 | CN1160062C Pharmaceutical formulation comprising omeprazole |
| 08/03/2004 | US6770763 Asymmetric synthesis of amino-pyrrolidinones |
| 08/03/2004 | US6770668 Pharmaceutically active compounds and methods of use |
| 08/03/2004 | US6770666 Fused-ring compounds and use thereof as drugs |
| 08/03/2004 | US6770650 Cyclic amine derivatives-CCR-3 receptor antagonists |
| 08/03/2004 | US6770648 Antidiabetic agents |
| 08/03/2004 | US6770647 Osteoporosis; rheumatic diseases |
| 08/03/2004 | US6770637 Substituted 4-phenyl-pyridine compounds with activity as antagonists of neurokinin 1 receptors |
| 08/03/2004 | US6770627 Piperizine-4-phenyl derivatives as inhibitors of the interaction between mdm2 and p 53 |
| 08/03/2004 | US6770597 Benzohydrazide derivatives as herbicides and desiccant compositions containing them |
| 08/03/2004 | US6770259 Simultaneous dual isotope imaging of cardiac perfusion and cardiac inflammation |
| 08/03/2004 | CA2113530C Process for the preparation of polyhalogenated benzotrichlorides and benzoyl chlorides and new trihalogeno-benzotrichlorides and -benzoyl chlorides |
| 07/29/2004 | WO2004063193A1 4-{`3-(sulfonylamino) phenyl! `1-(cyclymethyl) piperidin-4-ylidene! methyl} benazmide derivatives as delta opioid receptor ligands for the treatment of pain, anxiety and functional gastrointestinal disorder |
| 07/29/2004 | WO2004063180A1 Substituted heterocyclic compounds |
| 07/29/2004 | WO2004063171A1 N- (1-benzyl-2-oxo-2- (1-piperazinyl) ethyl) -1-piperidincarboxamid-derivatives and related compounds use as cgrp-antagonists for treating a headache |
| 07/29/2004 | WO2004063169A1 Hydroxamid acid derivatives as histone deacetylase (hdac) inhibitors |
| 07/29/2004 | WO2004063163A1 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands |
| 07/29/2004 | WO2004063159A1 Nitrogenous heterocyclic derivative and organic electroluminescent element employing the same |
| 07/29/2004 | WO2004063156A1 Novel indole derivates as fabp-4 inhibitors |
| 07/29/2004 | WO2004063150A2 Diagnostic and therapeutic alkyl piperidine/piperazine compounds and process |
| 07/29/2004 | WO2004062663A1 Use of substituted 2-phenylbenzimidazoles as medicaments |
| 07/29/2004 | WO2004062629A2 Apoptolidin analogs and derivatives for inducing apoptosis in transformed cells |
| 07/29/2004 | WO2004062613A2 Hiv integrase inhibitors |
| 07/29/2004 | WO2004062609A2 Pyrimidine derivatives as il-8 receptor antagonists |
| 07/29/2004 | WO2004062571A2 Substantially pure cilostazol and processes for making same |
| 07/29/2004 | WO2004062562A2 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 07/29/2004 | WO2004050039A3 Spirocyclic ureas, compositions containing such compounds and methods of use |
| 07/29/2004 | WO2004050024A3 3-aminopyrrolidine derivatives as modulators of chemokine receptors |
| 07/29/2004 | WO2004045533A3 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 07/29/2004 | WO2004041777A3 Heteroarylpiperidine modulators of chemokine receptor activity |
| 07/29/2004 | WO2004033431A3 Hydroxypyrazoles for use against metabolic-related disorders |
| 07/29/2004 | WO2004031401A3 Novel tyrosine kinases inhibitors |
| 07/29/2004 | WO2004018419B1 Benzimidazole quinolinones and uses thereof |
| 07/29/2004 | WO2004014868A8 Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors |
| 07/29/2004 | WO2004013091A3 4-anilido substituted quinazolines and use thereof as inhibitors of epidermal growth factor receptor kinases |
| 07/29/2004 | WO2003094861A3 Bis-benzimidazoles and related compounds as potassium channel modulators |
| 07/29/2004 | WO2003059355A8 Quinazolinone compounds in combined modalities for improved cancer treatment |
| 07/29/2004 | WO2003040107A8 Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity |
| 07/29/2004 | US20040147752 Carbazole derivatives for the treatment of NPY related diseases |
| 07/29/2004 | US20040147746 Such as N-{2-[2-(5-Bromo-2-methoxy-phenyl)-ethyl]-3-fluoro-benzoyl}-N'-butyl-guanidine; involuntary weight loss disorders |
| 07/29/2004 | US20040147745 Novel compounds and compositions as protease inhibitors |
| 07/29/2004 | US20040147744 2-(N-cyano-N-methylamino)-4-chloro-5-(2,4,6-trifluorophenyl)-6-(1,1,1-trifluoroprop-2-ylamino)-pyrimidine; synthesis; treating plant locus |
| 07/29/2004 | US20040147741 Heptadecapeptide nociceptin opioid receptor modulators; pain relievers; synthesis |
| 07/29/2004 | US20040147586 Antiproliferative agents; anticancer agents; glioblastomas; antidiabetic agents; autoimmune disorders; skin disorders; antiarthritic agents; antiinflammatory agents; cardiovascular disorders |
| 07/29/2004 | US20040147580 Therapy for bacteria infections |
| 07/29/2004 | US20040147579 Antiinflammatory agents; antiarthritic agents; antihistamines; respiratory system disorders; glomerulonephitis; inflammatory bowel disorders; Crohn's disease; skin disorders; tumor necrosis factor sensitive disease |
| 07/29/2004 | US20040147577 Heterocyclic compounds |
| 07/29/2004 | US20040147576 Cardiovascular disorders; thrombosis; anticoagulants |
| 07/29/2004 | US20040147573 Metalloproteinase inhibitors |
| 07/29/2004 | US20040147569 Cell differentiation inducer |
| 07/29/2004 | US20040147558 Synthesis of 3-amino-thalidomide and its enantiomers |
| 07/29/2004 | US20040147556 Analgesics; anxiolytuic agents; gastrointestinal disorders |
| 07/29/2004 | US20040147555 Anticoagulants; brain disorders; blood circulation disorders; myocardial infraction |
| 07/29/2004 | US20040147553 Efficiency; side effect reduction; antiarthriutic agents; autoimmune diseases |
| 07/29/2004 | US20040147535 Endothelial growth factor; angiogenesis inhibitor; antitumor agents; skin disorders; endometriosis; Crohn's disease ; leukemia; antiarthritic agents |
| 07/29/2004 | US20040147529 Preferentially substituted calcium channel blockers |
| 07/29/2004 | US20040147520 Sulfonylquinoxalone acetamide derivatives and related compounds as bradykinin antagonists |
| 07/29/2004 | US20040147519 Sulfonylquinoxalone acetamide derivatives as bradykinin antagonists |
| 07/29/2004 | US20040147518 4-[3-(3-chloro-6-methoxyquinolin-4-yl)propyl]-1-[2-(thien-2-yl)thioethyl]piperidine-4-carboxylic acid or salt for example; antibacterial activity |
| 07/29/2004 | US20040147516 Blocking interleukins; antiinflammatory agents; autoimmune diseases ; antiarthritic agents; osteoporosis |
| 07/29/2004 | US20040147512 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 07/29/2004 | US20040147511 Prevent premature labor; dymenorrhea |
| 07/29/2004 | US20040147507 Compositions useful as inhibitors of JAK and other protein kinases |
| 07/29/2004 | US20040147506 Muscarinic acetylcholine receptor antagonist; Parkinson's disease; dystonia; analgesics; irritable bowel syndrome |
| 07/29/2004 | US20040147502 Beta lactam compounds and their use as inhibitors of tryptase |
| 07/29/2004 | US20040147481 For the manufacture of a medicament for therapy of gastric acid-related diseases and gastro intestinal inflammatory diseases in animals and man, such as gastric ulcer, duodenal ulcer, reflex oesophagitis and gastritis |
| 07/29/2004 | US20040147454 Aspartyl protease inhibitors |